↓ Skip to main content

Increase of PD-L1 expressing B-precursor ALL cells in a patient resistant to the CD19/CD3-bispecific T cell engager antibody blinatumomab

Overview of attention for article published in Journal of Hematology & Oncology, October 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

patent
4 patents

Citations

dimensions_citation
139 Dimensions

Readers on

mendeley
123 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Increase of PD-L1 expressing B-precursor ALL cells in a patient resistant to the CD19/CD3-bispecific T cell engager antibody blinatumomab
Published in
Journal of Hematology & Oncology, October 2015
DOI 10.1186/s13045-015-0213-6
Pubmed ID
Authors

Thomas Köhnke, Christina Krupka, Johanna Tischer, Thomas Knösel, Marion Subklewe

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 123 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Korea, Republic of 1 <1%
Japan 1 <1%
Chile 1 <1%
United States 1 <1%
Unknown 119 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 29 24%
Student > Master 18 15%
Student > Bachelor 18 15%
Student > Ph. D. Student 15 12%
Student > Doctoral Student 8 7%
Other 18 15%
Unknown 17 14%
Readers by discipline Count As %
Medicine and Dentistry 40 33%
Agricultural and Biological Sciences 21 17%
Biochemistry, Genetics and Molecular Biology 13 11%
Immunology and Microbiology 13 11%
Pharmacology, Toxicology and Pharmaceutical Science 7 6%
Other 10 8%
Unknown 19 15%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 September 2022.
All research outputs
#3,907,044
of 25,837,817 outputs
Outputs from Journal of Hematology & Oncology
#350
of 1,308 outputs
Outputs of similar age
#50,679
of 292,362 outputs
Outputs of similar age from Journal of Hematology & Oncology
#5
of 23 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,308 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.6. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 292,362 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.